UB Paderborn / Katalog / Suche / in CDI

Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?

Arteriosclerosis, thrombosis, and vascular biology, 2019-10, Vol.39 (10), p.1938

2019

Volltextzugriff (PDF)

Vitamin D receptor polymorphisms and diseases

Clinica chimica acta, 2006-09, Vol.371 (1), p.1-12

2006

Volltextzugriff (PDF)

Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort

Nephrology, dialysis, transplantation, 2022-03, Vol.37 (4), p.663-672

2022

Volltextzugriff (PDF)

Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases

The Journal of cell biology, 2007-05, Vol.177 (4), p.683-694

2007

Volltextzugriff (PDF)

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage

Mediators of inflammation, 2018-01, Vol.2018, p.8739473-22

2018

Volltextzugriff (PDF)

Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

Drugs (New York, N.Y.), 2021-09, Vol.81 (13), p.1467-1489

2021

Volltextzugriff (PDF)

The potential of targeting NMDA receptors outside the CNS

Expert opinion on therapeutic targets, 2015-03, Vol.19 (3), p.399-413

2015

Volltextzugriff (PDF)

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Nephrology, dialysis, transplantation, 2023-10, Vol.38 (11), p.2444-2455

2023

Volltextzugriff (PDF)

Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach

International journal of molecular sciences, 2021-04, Vol.22 (8), p.3887

2021

Volltextzugriff (PDF)

Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.3038-3050

2022

Volltextzugriff (PDF)

Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy

Nephrology, dialysis, transplantation, 2011-06, Vol.26 (6), p.1797-1802

2011

Volltextzugriff (PDF)

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

Scientific reports, 2023-01, Vol.13 (1), p.1253-1253, Article 1253

2023

Volltextzugriff (PDF)

Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1α‐Hydroxylase Expression in Vascular Smooth Muscle Cells

Journal of bone and mineral research, 2016-10, Vol.31 (10), p.1865-1876

2016

Volltextzugriff (PDF)

Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology

Mediators of inflammation, 2018-01, Vol.2018, p.2931049-14

2018

Volltextzugriff (PDF)

RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway

Circulation research, 2009-05, Vol.104 (9), p.1041-1048

2009

Volltextzugriff (PDF)

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD

Clinical journal of the American Society of Nephrology, 2016-02, Vol.11 (2), p.287-296

2016

Volltextzugriff (PDF)

Differential Effects of Vitamin D Analogs on Vascular Calcification

Journal of bone and mineral research, 2007-06, Vol.22 (6), p.860-866

2007

Volltextzugriff (PDF)

Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

Nephrology, dialysis, transplantation, 2019-12, Vol.34 (12), p.2079-2088

2019

Volltextzugriff (PDF)

Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness

Nutrients, 2020-08, Vol.12 (9), p.2631

2020

Volltextzugriff (PDF)

The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

PloS one, 2017-11, Vol.12 (11), p.e0186921-e0186921

2017

Volltextzugriff (PDF)

Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals

Atherosclerosis, 2014-08, Vol.235 (2), p.247-255

2014

Volltextzugriff (PDF)

New therapeutic targets in chronic kidney disease progression and renal fibrosis

Expert opinion on therapeutic targets, 2020-07, Vol.24 (7), p.655-670

2020

Volltextzugriff (PDF)

Glutamatergic Signaling Maintains the Epithelial Phenotype of Proximal Tubular Cells

Journal of the American Society of Nephrology, 2011-06, Vol.22 (6), p.1099-1111

2011

Volltextzugriff (PDF)

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

Scientific reports, 2017-09, Vol.7 (1), p.10654-15, Article 10654

2017

Volltextzugriff (PDF)

Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy

Journal of clinical medicine, 2021-09, Vol.10 (17), p.3980

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?

Vitamin D receptor polymorphisms and diseases

Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort

Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage

Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

The potential of targeting NMDA receptors outside the CNS

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach

Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy

Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1α‐Hydroxylase Expression in Vascular Smooth Muscle Cells

Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology

RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD

Differential Effects of Vitamin D Analogs on Vascular Calcification

Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness

The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals

New therapeutic targets in chronic kidney disease progression and renal fibrosis

Glutamatergic Signaling Maintains the Epithelial Phenotype of Proximal Tubular Cells

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy

Suchergebnisse filtern